BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37922162)

  • 1. AntiViralDL: Computational Antiviral Drug Repurposing Using Graph Neural Network and Self-Supervised Learning.
    Zhang P; Hu X; Li G; Deng L
    IEEE J Biomed Health Inform; 2023 Nov; PP():. PubMed ID: 37922162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graph Convolutional Network and Contrastive Learning Small Nucleolar RNA (snoRNA) Disease Associations (GCLSDA): Predicting snoRNA-Disease Associations via Graph Convolutional Network and Contrastive Learning.
    Zhang L; Chen M; Hu X; Deng L
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graph Neural Network with Self-Supervised Learning for Noncoding RNA-Drug Resistance Association Prediction.
    Zheng J; Qian Y; He J; Kang Z; Deng L
    J Chem Inf Model; 2022 Aug; 62(15):3676-3684. PubMed ID: 35838124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGCLDGA: unveiling drug-gene associations through simple graph contrastive learning.
    Fan Y; Zhang C; Hu X; Huang Z; Xue J; Deng L
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38754409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring ncRNA-Drug Sensitivity Associations Via Graph Contrastive Learning.
    Hu X; Jiang Y; Deng L
    IEEE/ACM Trans Comput Biol Bioinform; 2024 Apr; PP():. PubMed ID: 38578855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DTiGNN: Learning drug-target embedding from a heterogeneous biological network based on a two-level attention-based graph neural network.
    Muniyappan S; Rayan AXA; Varrieth GT
    Math Biosci Eng; 2023 Mar; 20(5):9530-9571. PubMed ID: 37161255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction.
    Gu Y; Zheng S; Yin Q; Jiang R; Li J
    Comput Biol Med; 2022 Nov; 150():106127. PubMed ID: 36182762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MVGCNMDA: Multi-view Graph Augmentation Convolutional Network for Uncovering Disease-Related Microbes.
    Hua M; Yu S; Liu T; Yang X; Wang H
    Interdiscip Sci; 2022 Sep; 14(3):669-682. PubMed ID: 35428964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGeRepDR: An enhanced genetic-based representation learning for drug repurposing using multiple biomedical sources.
    Muniyappan S; Rayan AXA; Varrieth GT
    J Biomed Inform; 2023 Nov; 147():104528. PubMed ID: 37858852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-supervised contrastive graph representation with node and graph augmentation.
    Duan H; Xie C; Li B; Tang P
    Neural Netw; 2023 Oct; 167():223-232. PubMed ID: 37660671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GCFMCL: predicting miRNA-drug sensitivity using graph collaborative filtering and multi-view contrastive learning.
    Wei J; Zhuo L; Zhou Z; Lian X; Fu X; Yao X
    Brief Bioinform; 2023 Jul; 24(4):. PubMed ID: 37427977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A computational framework for predicting novel drug indications using graph convolutional network with contrastive learning.
    Luo Y; Shan W; Peng L; Luo L; Ding P; Liang W
    IEEE J Biomed Health Inform; 2024 Apr; PP():. PubMed ID: 38607707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-task prediction-based graph contrastive learning for inferring the relationship among lncRNAs, miRNAs and diseases.
    Sheng N; Wang Y; Huang L; Gao L; Cao Y; Xie X; Fu Y
    Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37529914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Biological Feature and Heterogeneous Network Representation Learning-Based Framework for Drug-Target Interaction Prediction.
    Liu L; Zhang Q; Wei Y; Zhao Q; Liao B
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SADR: Self-Supervised Graph Learning With Adaptive Denoising for Drug Repositioning.
    Jin S; Zhang Y; Yu H; Lu M
    IEEE/ACM Trans Comput Biol Bioinform; 2024; 21(2):265-277. PubMed ID: 38190661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarity measures-based graph co-contrastive learning for drug-disease association prediction.
    Gao Z; Ma H; Zhang X; Wang Y; Wu Z
    Bioinformatics; 2023 Jun; 39(6):. PubMed ID: 37261859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MGRL: Predicting Drug-Disease Associations Based on Multi-Graph Representation Learning.
    Zhao BW; You ZH; Wong L; Zhang P; Li HY; Wang L
    Front Genet; 2021; 12():657182. PubMed ID: 34054920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
    Su X; Hu L; You Z; Hu P; Wang L; Zhao B
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous graph attention networks for drug virus association prediction.
    Long Y; Zhang Y; Wu M; Peng S; Kwoh CK; Luo J; Li X
    Methods; 2022 Feb; 198():11-18. PubMed ID: 34419588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Integrative Heterogeneous Graph Neural Network-Based Method for Multi-Labeled Drug Repurposing.
    Sadeghi S; Lu J; Ngom A
    Front Pharmacol; 2022; 13():908549. PubMed ID: 35873597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.